MedTrace Logo

Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients

NCT06862700 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 534

Last updated 2025-03-06

No results posted yet for this study

Summary

The goal of this observational study is to learn about the association between vasopressor exposure levels and outcomes in adults with cardiogenic shock receiving VA-ECMO. The main question it aims to answer is:

Does reduced exposure to vasopressors lower the 30-day mortality in patients with cardiogenic shock when receiving ECMO support? Participants who are receiving ECMO support for cardiogenic shock as part of their regular medical care will have their data collected, including information about their vasopressor use and mortality outcomes, over the course of the study.

Conditions

  • Cardiogenic Shock
  • Extracorporeal Membrane Oxygenation
  • Vasopressors
  • Hemodynamic Management
  • Critical Care
  • Heart Failure

Interventions

OTHER

Vasopressor Exposure Levels

This is an observational study with no active intervention. The study evaluates the association between natural variations in vasopressor exposure levels (measured by Vasoactive-Inotropic Score, VIS) and clinical outcomes in patients receiving VA-ECMO for cardiogenic shock.

Sponsors & Collaborators

  • Xiaotong Hou

    lead OTHER

Principal Investigators

  • Zhongtao Du, MD · Beijing Anzhen Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-26
Primary Completion
2027-01-01
Completion
2028-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06862700 on ClinicalTrials.gov